Co-expression and prognosis analyses of GLUT1–4 and RB1 in breast cancer

Co-expression and prognosis analyses of GLUT1–4 and RB1 in breast cancer

Abstract Background Current treatment methods for patients with triple-negative breast cancer (TNBC) are very limited, and the prognosis of TNBC is relatively poor. It has been reported that glucose transporter 1 (GLUT1) is overexpressed in breast cancer cells; however, its association with the prog...

Full description

Bibliographic Details
Main Authors: Xiaodan Zhang, Xiaocong Pang, Zhuo Zhang, Qianxin Liu, Hanxu Zhang, Qian Xiang, Yimin Cui
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Cancer
Subjects:
Triple-negative breast cancer
Glucose transporters
Metabolic inhibitory therapy
Individualized treatment
Metabolic plasticity
Online Access:https://doi.org/10.1186/s12885-021-08763-y

Internet

https://doi.org/10.1186/s12885-021-08763-y

Similar Items